The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

By Y. Taur, Robert R. Jenq, M. Perales, E. Littmann, Sejal Morjaria, Lilan Ling, Daniel No, Asia Gobourne, A. Viale, P. Dahi and 5 more. Blood, 2014

801 citations recorded by the source corpus.

Subfields: Infectious Diseases, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/36245a45a28734d943bc0b6fea749337bc4715df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Y. Taur
2. Eric G. Pamer
3. J. Wargo

In Molecular Biology

1. Y. Taur
2. M. Perales
3. M. V. D. van den Brink
4. V. Gopalakrishnan
5. J. Goldberg
6. Eric G. Pamer
7. Beth A. Helmink
8. Asia Gobourne

In Oncology

1. Eric G. Pamer
2. J. Wargo

Citations in the corpus

• Intestinal Blautia is associated with reduced death from graft-versus-host disease (2015, methodology): “Our group recently reported that increased bacterial diversity at the time of engraftment following allo BMT was associated with improved overall survival and reduced transplantrelated mortality, but in that heterogeneous patient population we did not find an association between diversity and GVHD [”
• The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. (2018, background): “…in long-term survival, with patients having a lower diversity of microbiota in their gut at the time of HSCT having shortened overall survival and higher mortality rates (specifically transplantrelated mortality), compared with those with a high diversity of gut microbiota (Taur et al., 2014).”